Patrick Forde

Patrick Forde, a consultant medical oncologist and Prendergast Chair in Immuno-Oncology at Trinity College Dublin, shares groundbreaking findings on lung cancer treatment. He discusses the promising results of immunotherapy administered before surgery, revealing most patients had no residual cancer afterward. Forde contrasts this with traditional chemotherapy, highlighting immunotherapy's milder side effects. The conversation also touches on Ireland's pivotal role in cancer clinical trials and the importance of patient advocacy in advancing treatment options.